R Dirk Allison Sells 12,500 Shares of Addus HomeCare Co. (NASDAQ:ADUS) Stock

Addus HomeCare Co. (NASDAQ:ADUS) CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at $17,476,034.52. The trade was a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Addus HomeCare Stock Down 2.5 %

NASDAQ ADUS opened at $121.29 on Friday. Addus HomeCare Co. has a 52 week low of $85.43 and a 52 week high of $136.12. The firm has a 50 day moving average of $127.69 and a two-hundred day moving average of $123.50. The stock has a market capitalization of $2.20 billion, a PE ratio of 27.76, a price-to-earnings-growth ratio of 2.15 and a beta of 1.04.

Addus HomeCare (NASDAQ:ADUS) last posted its earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.03 earnings per share. On average, equities research analysts expect that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on ADUS shares. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer increased their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research note on Monday, September 23rd. Stephens boosted their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. TD Cowen increased their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a research report on Thursday, August 8th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Institutional Trading of Addus HomeCare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its holdings in shares of Addus HomeCare by 1.5% in the 1st quarter. Vanguard Group Inc. now owns 1,276,467 shares of the company’s stock valued at $131,910,000 after buying an additional 19,027 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its stake in Addus HomeCare by 4.7% in the first quarter. CANADA LIFE ASSURANCE Co now owns 16,837 shares of the company’s stock valued at $1,738,000 after acquiring an additional 761 shares in the last quarter. EntryPoint Capital LLC purchased a new position in shares of Addus HomeCare during the first quarter worth about $44,000. Lazard Asset Management LLC increased its position in shares of Addus HomeCare by 11.9% during the first quarter. Lazard Asset Management LLC now owns 5,128 shares of the company’s stock worth $529,000 after purchasing an additional 547 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its holdings in shares of Addus HomeCare by 683.7% in the 1st quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock valued at $5,703,000 after purchasing an additional 48,146 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.